Sorrento Therapeutics, Inc.'s Bankruptcy Court Issues Temporary Restraining Order Against Brokerage Firms And Suspends Short-Sales Of Dividended Scilex Stock
Portfolio Pulse from Benzinga Newsdesk
Sorrento Therapeutics, Inc.'s bankruptcy court has issued a temporary restraining order against brokerage firms and suspended short-sales of its dividended Scilex stock.

June 15, 2023 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The suspension of short-sales of Scilex stock due to Sorrento Therapeutics' bankruptcy court order may impact SCLX's stock price.
The temporary restraining order against brokerage firms and suspension of short-sales of Scilex stock directly affects Scilex (SCLX). This may lead to increased volatility in the stock price, but it is uncertain whether the impact will be positive or negative in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Sorrento Therapeutics' bankruptcy court order suspends short-sales of Scilex stock, potentially affecting SRNEQ's stock price.
The temporary restraining order against brokerage firms and suspension of short-sales of Scilex stock directly affects Sorrento Therapeutics, Inc. (SRNEQ). This may lead to increased volatility in the stock price, but it is uncertain whether the impact will be positive or negative in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100